Horizon Therapeutics plc Donates Additional $1.2 Million to Support COVID-19 Relief Efforts in Illinois & Other Impacted U.S....
November 30 2020 - 8:00AM
Business Wire
- Company has provided
more than $3.7 million to COVID-19 response and relief
efforts -
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it
has provided $1.2 million in additional funding to U.S and
international organizations to support COVID-19 relief efforts,
including: The Chicago Community Trust, The Lake County Community
Foundation, Silicon Valley Community Foundation, Greater Washington
Community Foundation, Americares, ALONE, Family Carers Ireland,
Enable Ireland and Toronto Foundation.
Throughout 2020, Horizon has also provided more than $1 million
to advocacy organizations to support COVID-19 relief initiatives
for people living with rare and rheumatic diseases. This includes
educational resources, emergency financial relief and internet
connectivity to facilitate continued care via telehealth.
“We recognize that the COVID-19 pandemic is currently impacting
more families, communities and organizations than ever before,”
said Tim Walbert, chairman, president and chief executive officer,
Horizon. “As a global company, we believe it is our fundamental
responsibility to support these foundations and organizations so
they can thrive and continue to help the communities they
serve.”
“While the devastating health and economic crises caused by
COVID-19 has disproportionately impacted Chicago’s Black and Latinx
communities, we have a once-in-a-generation opportunity to build a
more equitable recovery,” said Dr. Helene Gayle, president, chief
executive officer, The Chicago Community Trust. “We are grateful
for the support of Horizon Therapeutics as we know it’s going to
take an unprecedented coalition, across philanthropy, business and
communities, to transform the systems that have held back
communities of color for centuries.”
“Horizon Therapeutics is among Americares most dedicated
partners, consistently providing product donations and annual
support that helps us prepare for and respond to emergencies, and
fuels our ongoing health programs,” said Christine Squires,
president, chief executive officer, Americares. “This donation will
allow us to support U.S. safety net clinics as they leverage
telehealth technology so patients can access the care they need
from home, without worrying about putting themselves or others at
risk of COVID-19 infection.”
About Horizon
Horizon is focused on researching, developing and
commercializing medicines that address critical needs for people
impacted by rare and rheumatic diseases. Our pipeline is
purposeful: we apply scientific expertise and courage to bring
clinically meaningful therapies to patients. We believe science and
compassion must work together to transform lives. For more
information on how we go to incredible lengths to impact lives,
please visit www.horizontherapeutics.com and follow us on Twitter,
LinkedIn, Instagram and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201130005349/en/
U.S. Media Contact: Geoff Curtis Executive Vice
President, Corporate Affairs and Chief Communications Officer
media@horizontherapeutics.com
Investor Contacts: Tina Ventura Senior Vice
President, Investor Relations
Investor-relations@horizontherapeutics.com
Ruth Venning Executive Director, Investor Relations
Investor-relations@horizontherapeutics.com
Ireland Media Contact: Gordon MRM Ray Gordon
ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024